{"id":"W4298147607","doi":"10.1200/jco.2022.40.28_suppl.017","title":"Real-world cost effectiveness of first-line pembrolizumab for advanced melanoma: A population-based study by the Canadian Real-world Evidence Value for Cancer Drugs (CanREValue) Collaboration.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre; Queen's University","funders":"","keywords":"Medicine; Ipilimumab; Pembrolizumab; Population; Quality of life (healthcare); Demography; Internal medicine; Cancer; Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00395921,0.0005771129,0.00105675,0.001723177,0.000629428,0.001565989,0.001112679,0.0008293968,0.001973889],"category_scores_gemma":[0.01228609,0.0003779471,0.003142062,0.005115115,0.0004578358,0.0005643097,0.0007543414,0.001515372,0.0001613463],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02377454,"about_ca_system_score_gemma":0.01369643,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.795761,"about_ca_topic_score_gemma":0.7861971,"domain_scores_codex":[0.9969483,0.001199354,0.0002921967,0.0003270863,0.0008572828,0.0003758129],"domain_scores_gemma":[0.9930673,0.001749048,0.002393054,0.0005298633,0.001544259,0.0007164588],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01127286,0.0007491772,0.9093994,0.002228894,0.0212138,0.0002967697,0.000553151,0.006931596,0.0002616774,0.001831725,0.01757922,0.02768176],"study_design_scores_gemma":[0.002526431,0.000707684,0.9759361,0.0006701585,0.005876681,0.0002364628,0.0004920602,0.004894918,0.0001102042,0.0004410257,0.007980758,0.0001275306],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9225873,0.01186488,0.0006361767,0.001261337,0.00006220169,0.0006335442,0.06059595,0.00002598378,0.002332502],"genre_scores_gemma":[0.9806712,0.001924336,0.0006763417,0.0002490135,0.00003535429,0.000307715,0.01575644,0.00001030008,0.0003694239],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9762254,"threshold_uncertainty_score":0.4108835,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4125170398849206,"score_gpt":0.563294581362455,"score_spread":0.1507775414775345,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}